Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ARROWHEAD-PHARMACEUTICALS-26864651/news/Arrowhead-Announces-Interim-Results-from-Ongoing-Phase-1-2-Study-of-ARO-C3-for-Treatment-of-Compleme-43122647/?utm_source=whatsapp&utm_medium=social&utm_campaign=share